Botanix Pharmaceuticals Ltd has released a press release.
DEA Scheduling Decision Supports Botanix Approach
Filed with ASX ·
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Botanix Pharmaceuticals Limited on 6ix
Earlier from Botanix Pharmaceuticals
- Botanix Secures Commercial-Scale Synthetic Cannabidiol
- Reinstatement to Official Quotation - 15 July 2016
- Suspension
- Prospectus - Botanix Pharmaceuticals
- Human Clinical Study for an Oral Treatment for Osteoporosis
Later from Botanix Pharmaceuticals
- Botanix Accelerates Clinical Program with First Human Study
- Botanix Announces Positive Human Trial Data
- Quarterly Cashflow Report
- Botanix Announces Expansion of Permetrex License
- Botanix Announces Filing of New Permetrex Product Patents
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals